miR-26b-5p regulates TCF-4 so as to influence hADMSCs’ adipogenic differentiation. (A) qPCR revealed that when hADMSCs were co-transfected with an miR-26b-5p mimic and EX-TCF7L2, they exhibited significant increases in the expression of C/EBP, PPARγ, and aP2, and significant decreases in the expression of TCF7L2 and β-catenin relative to cells co-transfected with miR-26b-5p and EX-Ctrl constructs. (B) Western blotting revealed that when hADMSCs were co-transfected with an miR-26b-5p mimic and EX-TCF7L2, they exhibited significant increases in C/EBP, PPARγ, and aP2 levels, and significant decreases in levels of TCF-4, cytoplasmic β-catenin, and nuclear β-catenin. (C) Nuclear β-catenin staining intensity was reduced in cells transfected with an miR-26b-5p mimic and EX-TCF7L2. (D) qPCR revealed that when hADMSCs were co-transfected with an miR-26b-5p inhibitor and siTCF7L2 they exhibited significant decreases in the expression of C/EBP, PPARγ, and aP2, and significant increases in the expression of TCF7L2 and β-catenin relative to cells co-transfected with an miR-26b-5p inhibitor and siR-Ctrl constructs. (E) Western blotting revealed that when hADMSCs were co-transfected with an miR-26b-5p inhibitor and siTCF7L2 they exhibited significant decreases in C/EBP, PPARγ, and aP2 levels, as well as significant increases in levels of TCF-4, cytoplasmic β-catenin, and nuclear β-catenin. (F) hADMSCs transfected with miR-26b-5p inhibitor and siTCF7L2 exhibited significant decreases nuclear β-catenin fluorescence intensity. *P < 0.05. GAPDH: glyceraldehyde 3-phosphate dehydrogenase; hADMSC: human adipose-derived mesenchymal stem cell; PPARγ: peroxisome proliferator-activated receptor γ; qPCR: quantitative polymerase chain reaction; TCF-4: T cell factor 4.